智通财经APP讯，精锋医疗-B(02675)公布配发结果，公司全球发售2772.22万股H股，超额分配发售415.83万股。香港公开发售项下最终发售股份数目占全球发售的(超额分配后)8.70%，国际发售项下最终发售股份数目占全球发售的(超额分配后)91.30%。每股发售价43.24港元，全球发售净筹约11.17亿港元。每手100股，预期股份将于2026年1月8日上午九时正在联交所开始买卖。
其中，香港公开发售获1091.94倍认购，国际发售获25.18倍认购。
智通财经APP讯，精锋医疗-B(02675)公布配发结果，公司全球发售2772.22万股H股，超额分配发售415.83万股。香港公开发售项下最终发售股份数目占全球发售的(超额分配后)8.70%，国际发售项下最终发售股份数目占全球发售的(超额分配后)91.30%。每股发售价43.24港元，全球发售净筹约11.17亿港元。每手100股，预期股份将于2026年1月8日上午九时正在联交所开始买卖。
其中，香港公开发售获1091.94倍认购，国际发售获25.18倍认购。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.